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Abstract
©  2015  International  Spinal  Cord  Society  Study  design:Experimental  study.Objective:To
evaluate the treatment of spinal cord injury with glial cell-derived neurotrophic factor (GDNF)
delivered using an adenoviral vector (AdV-GDNF group) in comparison with treatment performed
using human umbilical cord blood mononuclear cells (UCB-MCs)-transduced with an adenoviral
vector  carrying  the  GDNF  gene  (UCB-MCs+AdV-GDNF  group)  in  rat.Setting:Kazan,  Russian
Federation.Methods:We examined the efficacy of AdV-GDNF and UCB-MCs+AdV-GDNF therapy
by conducting behavioral tests on the animals and morphometric studies on the spinal cord,
performing immunofluorescence analyses on glial cells, investigating the survival and migration
potential of UCB-MCs, and evaluating the expression of the recombinant GDNF gene.Results:At
the 30th postoperative day, equal positive locomotor recovery was observed after both direct
and cell-based GDNF therapy. However, after UCB-MCs-mediated GDNF therapy, the area of
preserved tissue and the number of spared myelinated fibers were higher than those measured
after direct GDNF gene therapy. Moreover, we observed distinct changes in the populations of
glial cells; expression patterns of the specific markers for astrocytes (GFAP, S100B and AQP4),
oligodendrocytes (PDGFαR and Cx47) and Schwann cells (P0) differed in various areas of the
spinal cord of rats treated with AdV-GDNF and UCB-MCs+AdV-GDNF.Conclusion:The differences
detected in the AdV-GDNF and UCB-MCs+AdV-GDNF groups could be partially explained by the
action of UCB-MCs. We discuss the insufficiency and the advantages of these two methods of
GDNF gene delivery into the spinal  cord after  traumatic  injury.Spinal  Cord advance online
publication, 29 September 2015; doi:10.1038/sc.2015.161.
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